News

Pregnancy is an incredible journey, but for women with celiac disease it is still an ongoing challenge. Properly managing a nutritionally balanced and strict gluten-free diet during the journey to motherhood continues to be a difficult task. Current guidelines [1] do not provide recommendations for determining the appropriate energy intake for celiac women during pregnancy.

At Dr. Schär, every employee is the unique, irreplaceable voice of a large community. This richness translates into active listening and appreciation of each individual’s ideas, the beating heart that drives each of our initiatives.

An extraordinary example is ‘in.pegno’, the project created by the public artist and street poet ivan and curated by Arte Sella museum, which has brought the façade of the Borgo Valsugana plant (Italy) to life, transforming it into a participatory work of art, testimony to the commitment and collective spirit that characterise our company.

1.800 employees, spread across 18 sites in 12 different countries worldwide, 43% women, 4 generations in ongoing collaborative dialogue. Distinctive characteristics: using their skills, ability to work as a team and passion for their work to make a difference, improving the lives of people with special nutritional needs. This is the picture of our company population, a community of which we are proud and for which we are committed to a healthy and fair working environment.

The gluten-free diet is considered the gold standard and the only effective treatment for celiac disease. When followed correctly, it reduces inflammation and promotes gut healing, minimizing the risk of associated comorbidities such as bone density loss, vitamin and mineral deficiencies, the development of other autoimmune diseases, subfertility in both men and women, neurological complications, and the risk of small bowel cancer.

It does, however, still fall victim to stigma, which may contribute to low adherence to treatment.

Dr. Schär SPA Chairman, Ulrich Ladurner, has announced that Hannes Berger is the new CEO of the world leading company in specialised and gluten-free nutrition. Hannes Berger has held key positions in the Company for almost twenty years and has been a member of the Board of Directors since it was introduced. Hannes began his new role in January 2023, replacing former CEO Phillip Schoeller.

Gluten-free products are a matter of trust. They need to be safe because they represent the only treatment for those suffering from gluten-related disorders. They also need to be tasty because mealtimes should not be unpleasant experiences.

The prevalence of coeliac disease is estimated to be on the rise, but the number of diagnoses remains too low. 

Coeliac disease, the most common autoimmune disease in children, which primarily involves the intestine and the immune system, has an overall prevalence of 1% [1]. An estimated figure, however, that does not take either wide local variations or undiagnosed cases into account. Sweden and Finland, for example, but also certain geographically localised populations of India and North Africa are among the countries with a higher prevalence. In Asia, the condition is extremely rare and the causes are still unknown, although they may be related to the eating habits of that area.

A varied and balanced diet plays a crucial role in maintaining a healthy lifestyle. However, for some people suffering from chronic conditions, diet is not just a good practice but a key aspect an integral part of their treatment. A gluten-free diet is currently the only treatment available for people with celiac disease or gluten-related conditions. A low-protein diet can be a valuable ally in reducing the progression of chronic renal failure. Numerous studies have confirmed the value of the ketogenic diet in cases of fat malabsorption and maldigestion and in the treatment of neurological disorders. One in four adults suffers from metabolic syndrome, in which a correct and balanced diet is an ally in preventing a deterioration in health.

“I believe we have a moral duty to protect the planet for future generations: our children and grandchildren - this is the profound conviction of Ulrich Ladurner - Chairman of Dr. Schär - which guides the strategies and projects pursued by all of us at Dr. Schär”.

Biodiversity is one of the most precious resources on Earth. We are committed to preserving it by promoting a sustainable agriculture and an ‘accompanied’ supply chain free of negative impacts on forests, but also by implementing research projects aimed at the recovery of minor crops such as sorghum, buckwheat, and millet. A concrete example of this approach is VItaMi - Varietà Italiane di Miglio - a project that aims to select new millet varieties adapted to European soil and climatic conditions, that will be grown by partner farmers to produce the Schär products of the future.